Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Tascini

Showing results (1-10 of 345) with videos related to

Pageof 35
Sort By:
Urologia|August 8, 2018
Antibiotic stewardship: ripartiamo dalla pratica clinicaCarlo Tascini
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 23, 2024
Chances/Challenges of the Role of New Beta-lactamase Inhibitors Against the Growing Threat of NDM-producing Escherichia coli With Penicillin-binding Protein 3 MutationsClaudia Fabrizio, Carlo Tascini
Infection|March 20, 2021
Correction to: Mono vs. combo regimens with novel beta-lactam/beta-lactamase inhibitor combinations for the treatment of infections due to carbapenemase-producing Enterobacterales: insights from the literatureSimone Meini, Bruno Viaggi, Carlo Tascini
Infection|February 3, 2021
Mono vs. combo regimens with novel beta-lactam/beta-lactamase inhibitor combinations for the treatment of infections due to carbapenemase-producing Enterobacterales: insights from the literatureSimone Meini, Bruno Viaggi, Carlo Tascini
Antimicrobial Agents and Chemotherapy|May 28, 2026
Case Commentary: When susceptibility is not enough in recurrent <i>Burkholderia cenocepacia</i> infectionSimone Giuliano, Paolo Gaibani, Carlo Tascini
The New England Journal of Medicine|May 29, 2024
Cefepime-Taniborbactam in Complicated Urinary Tract InfectionSimone Lanini, Tommaso Cai, Carlo Tascini
Future Microbiology|February 12, 2009
Prulifloxacin: clinical studies of a broad-spectrum quinolone agentGianluca Giannarini, Carlo Tascini, Cesare Selli
JAMA|April 25, 2023
Review of Progress and Challenges in Bacterial MeningitisSimone Giuliano, Francesco Sbrana, Carlo Tascini
The Journal of Antibiotics|February 5, 2026
Synergy evaluation of cefepime/enmetazobactam in combination with novel β-lactam/β-lactamase inhibitor combinations (βL/βLICs) against Klebsiella pneumoniae carrying different bla<sub>KPC</sub> variantsCarlo Tascini, Giulia Zocche, Paolo Gaibani
Intensive Care Medicine|February 22, 2015
Acid-suppressant therapy does not influence absorption of azoles used in candidemiaBruno Viaggi, Carlo Tascini, Francesco Menichetti
Pageof 35

Showing results (1-10 of 345) with videos related to

Sort By:
Pageof 35
Urologia|August 8, 2018
Antibiotic stewardship: ripartiamo dalla pratica clinicaCarlo Tascini
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 23, 2024
Chances/Challenges of the Role of New Beta-lactamase Inhibitors Against the Growing Threat of NDM-producing Escherichia coli With Penicillin-binding Protein 3 MutationsClaudia Fabrizio, Carlo Tascini
Infection|March 20, 2021
Correction to: Mono vs. combo regimens with novel beta-lactam/beta-lactamase inhibitor combinations for the treatment of infections due to carbapenemase-producing Enterobacterales: insights from the literatureSimone Meini, Bruno Viaggi, Carlo Tascini
Infection|February 3, 2021
Mono vs. combo regimens with novel beta-lactam/beta-lactamase inhibitor combinations for the treatment of infections due to carbapenemase-producing Enterobacterales: insights from the literatureSimone Meini, Bruno Viaggi, Carlo Tascini
Antimicrobial Agents and Chemotherapy|May 28, 2026
Case Commentary: When susceptibility is not enough in recurrent <i>Burkholderia cenocepacia</i> infectionSimone Giuliano, Paolo Gaibani, Carlo Tascini
The New England Journal of Medicine|May 29, 2024
Cefepime-Taniborbactam in Complicated Urinary Tract InfectionSimone Lanini, Tommaso Cai, Carlo Tascini
Future Microbiology|February 12, 2009
Prulifloxacin: clinical studies of a broad-spectrum quinolone agentGianluca Giannarini, Carlo Tascini, Cesare Selli
JAMA|April 25, 2023
Review of Progress and Challenges in Bacterial MeningitisSimone Giuliano, Francesco Sbrana, Carlo Tascini
The Journal of Antibiotics|February 5, 2026
Synergy evaluation of cefepime/enmetazobactam in combination with novel β-lactam/β-lactamase inhibitor combinations (βL/βLICs) against Klebsiella pneumoniae carrying different bla<sub>KPC</sub> variantsCarlo Tascini, Giulia Zocche, Paolo Gaibani
Intensive Care Medicine|February 22, 2015
Acid-suppressant therapy does not influence absorption of azoles used in candidemiaBruno Viaggi, Carlo Tascini, Francesco Menichetti
Pageof 35